Knee News and Research

RSS

Patients with metabolic syndrome are more likely to have complications after total joint replacement

In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers found that total joint replacement patients with three or more metabolic syndrome risk factors were almost three times as likely to have complications within the first year after joint replacement.

11 Mar 2014

Total joint replacement may reduce risk for cardiac events and boost long-term survival

Hip and knee replacements have long been known to reduce pain and increase mobility in persons with moderate-to-severe arthritis. A study presented at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) also found that total joint replacement (TJR) may reduce the risk for "cardiac events," including heart attack and stroke, and boost long-term survival.

11 Mar 2014

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients.

11 Mar 2014

Glucosamine not reduces knee cartilage deterioration among individuals with chronic knee pain

A short-term study found that oral glucosamine supplementation is not associated with a lessening of knee cartilage deterioration among individuals with chronic knee pain.

11 Mar 2014

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Today, United Orthopedic Corporation (UOC) - a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments - announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA.

7 Mar 2014

Lucideon now provides wear testing and debris analysis for orthopaedic implant manufacturers across Europe and the US

Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.

From Lucideon 4 Mar 2014

Protamine antidote can be effective in reversing low-molecular-weight heparin

Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme - uncontrolled bleeding - in response to low-molecular-weight heparin, there is no antidote.

4 Mar 2014

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Since 2009, the eight states (Alabama, Illinois, Louisiana, Massachusetts, New York, Utah, Virginia, and Wisconsin) participating in the Robert Wood Johnson Foundation's Maximizing Enrollment program have worked to streamline and simplify enrollment systems, policies, and processes for children and those eligible for coverage in 2014. ... States [focused] on five key areas: 1) applications, 2) eligibility determinations, 3) renewals and transfers, 4) notices, and 5) business processes.

3 Mar 2014

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Ortho Development Corporation has received FDA clearance for its patented KASM Knee Articulating Spacer Molds. KASM is a cement spacer mold intended for use in treating patients who develop an infection after undergoing total knee replacement surgery.

28 Feb 2014

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the Phase 3 clinical trial assessing the safety and efficacy of EXPAREL® (bupivacaine liposome injectable suspension) in femoral nerve block for total knee arthroplasty met its primary efficacy endpoint.

27 Feb 2014

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.

26 Feb 2014

Study: Patients more likely to die in hospitals when cared for by nurses with heavy workloads

Patients are more likely to die after common surgical procedures when they are cared for in hospitals with heavier nurse workloads and fewer nurses with bachelor's degrees, concludes the largest investigation of nursing and hospital outcomes in Europe to date, published in The Lancet.

26 Feb 2014

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.

25 Feb 2014

Zimmer issues 5 new patents directed to Subchondroplasty Procedure

Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today announced that the United States Patent and Trademark Office has issued five new patents directed to the Subchondroplasty® Procedure, the innovative new joint preservation procedure developed by Zimmer Knee Creations: U.S. Patent No. 8,551,178, U.S. Patent No. 8,574,303, U.S. Patent No. 8,608,802, U.S. Patent No. 8,617,166 and U.S. Patent No. 8,623,089.

25 Feb 2014

Public sector reduces part-time shifts to avoid health law

Despite the administration's delays of the employer mandate, cities, counties and public schools have limited part-timers' work hours so they don't have to offer health insurance, reports The New York Times. Other media outlets report on targeted enrollment pitches to taxicab drivers, restaurant workers and artists, and on the GOP's probe of an Accenture contract for work on healthcare.gov.

24 Feb 2014

Regional anesthesia may not make patients more prone to falls after knee replacement surgery

Two types of regional anesthesia do not make patients more prone to falls in the first days after having knee replacement surgery as some have previously suggested, according to a study based on nearly 200,000 patient records in the March issue of Anesthesiology.

21 Feb 2014

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.

20 Feb 2014

iASSIST device improves surgical precision, accuracy in total knee replacements

Each year, approximately 600,000 total knee replacement procedures are performed in the United States, a number that is expected to rise exponentially in the next decade as the population ages. Successful surgeries require precise alignment in the knee, a challenging task made even more daunting by the expected rise in procedures. To help meet this demand, UC San Diego Health System is the first in the nation to use iASSIST, a computer navigation system with Bluetooth-like technology that improves surgical precision and accuracy in total knee replacements, decreasing the need for revision surgery.

20 Feb 2014

Ways to help manage chronic pain

Musculoskeletal pain of the bone, joint and muscles is one of the most common reasons for primary care visits in the United States. According to a literature review appearing in a recent issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), chronic pain, or pain that persists beyond an expected period of healing, is estimated to affect 100 million Americans.

20 Feb 2014

Insurgical single-use orthopaedic power tools used in total knee replacement procedure

On February, 5, orthopaedic surgeon Thomas Ferro, MD, successfully performed a total knee replacement procedure using Insurgical single-use orthopaedic power tools. This operation marked the first time FDA cleared single-use, cordless, handheld power tools were used in an orthopaedic operation in the United States. Specialty surgical power tools used to cut and shape bone are required in over 1.5 million orthopaedic procedures annually in the United States.

12 Feb 2014

Knee News and Research

Patients with metabolic syndrome are more likely to have complications after total joint replacement

Total joint replacement may reduce risk for cardiac events and boost long-term survival

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Glucosamine not reduces knee cartilage deterioration among individuals with chronic knee pain

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Lucideon now provides wear testing and debris analysis for orthopaedic implant manufacturers across Europe and the US

Protamine antidote can be effective in reversing low-molecular-weight heparin

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Ortho Development receives FDA clearance for patented Knee Articulating Spacer Molds

Pacira Pharmaceuticals initiates Phase 3 clinical trial of EXPAREL in femoral nerve block

Anika Therapeutics receives marketing approval from FDA for MONOVISC injection

Study: Patients more likely to die in hospitals when cared for by nurses with heavy workloads

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

Zimmer issues 5 new patents directed to Subchondroplasty Procedure

Public sector reduces part-time shifts to avoid health law

Regional anesthesia may not make patients more prone to falls after knee replacement surgery

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

iASSIST device improves surgical precision, accuracy in total knee replacements

Ways to help manage chronic pain

Insurgical single-use orthopaedic power tools used in total knee replacement procedure

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News